Genetic Testing for SCD-Predisposing Cardiomyopathies/Channelopathies (Michael Ackerman, MD)

This grand round will provide the current state of genetic testing for the major SCD-predisposing genetic heart diseases in the young. The attendee will gain a keen understanding of the yield of the genetic testing for the major cardiomyopathies and channelopathies as well as the impact of a positive genetic test results across the triad (diagnostic, prognostic, and therapeutic) of medicine.
Objectives:
1. To recognize the various faces (“phenotypes”) of sudden death predisposing cardiomyopathies and channelopathies including hypertrophic cardiomyopathy (HCM) and long QT syndrome (LQTS)
2. To assess the currently available genetic tests for HCM and LQTS and evaluate their yield and their impact across the tria of medicine.
3. To interpret genetic tests and incorporate them into the practice of personalized medicine as probabilistic tests.


** This medical education program may contain graphic content. **
_________________________________

A DeBakey CV Education event

Presented by Houston Methodist DeBakey Heart & Vascular Center.

Building on Dr. Michael E. DeBakey’s commitment to excellence in education, Houston Methodist DeBakey CV Education is an epicenter for cardiovascular academic and clinical educational programs that support the provision of optimal care to patients suffering from cardiovascular conditions and diseases.

FOR MORE INFORMATION
DeBakey CV Education:
https://www.houstonmethodist.org/educ...

For the latest education and training opportunities from DeBakey CV Education: http://bit.ly/HMdebakeyemail

Follow Us:
Twitter:   / debakeycvedu  
Livestream: https://livestream.com/debakey
SmugMug: https://debakey.smugmug.com/

Want concise, relevant reviews of the hottest topics in CV medicine? Subscribe for FREE to the Methodist DeBakey Cardiovascular Journal for quarterly, peer-reviewed issues delivered to your door.
https://journal.houstonmethodist.org/